Skip to content
Loop Biz – Lifestyle
Author:
ODDIFACT
Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP (MabionCD20) in Immune Thrombocytopenia
August 26, 2026
ODDIFACT Receives European Commission Orphan Drug Designation for Infliximab in Kawasaki Disease
May 21, 2026